A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Elocon Indications, Dosage, Storage, Stability - Mometasone Furoate (nasal spray)
Elocon Indications, Dosage, Storage, Stability - Mometasone Furoate (nasal spray)
INDICATIONS
NASONEX Nasal Spray, 50 µg is indicated for the prophylaxis
and treatment of the nasal
symptoms of seasonal allergic
rhinitis and the treatment
of the nasal symptoms
of perennial allergic
rhinitis, in adults
and children 12 years of age
and older. In patients with
a known seasonal allergen
that precipitates nasal
symptoms of seasonal allergic
rhinitis, initiation
of prophylaxis with NASONEX Nasal Spray, 50 µg is recommended
2 to 4 weeks prior to the anticipated start of the pollen
season.
DOSAGE AND ADMINISTRATION
Adults and Children 12 Years of Age and Older
The usual recommended dose
for prophylaxis
and treatment of the
nasal symptoms of seasonal allergic
rhinitis and treatment
of the nasal symptoms
of perennial allergic
rhinitis is two sprays
(50 µg of mometasone furoate in each spray) in each nostril
once daily (total daily dose
of 200 µg).
In patients with a known seasonal allergen
that precipitates nasal
symptoms of seasonal allergic
rhinitis, prophylaxis
with NASONEX Nasal Spray, 50 µg (200 µg/day) is recommended
2 to 4 weeks prior to the anticipated start of the pollen
season.
Improvement in nasal
symptoms generally occurs within 2 days after the first dose. Maximum
benefit is usually achieved
within 1 to 2 weeks. Patients should use NASONEX Nasal Spray, 50
µg only once daily at a regular interval.
Prior to initial use
of NASONEX Nasal Spray, 50 µg, the pump
must be primed by actuating ten times or until a fine spray
appears. The pump may be stored unused for up to 1 week without
repriming. If unused for more than 1 week, reprime by actuating
two times, or until a fine spray appears.
Directions for Use
Illustrated Patient’s Instructions for Use accompany each package
of NASONEX Nasal Spray, 50 µg.
HOW SUPPLIED
NASONEX (mometasone furoate monohydrate) Nasal Spray, 50 µg
is supplied in a white, high- density,
polyethylene bottle
fitted with a white metered-dose, manual
spray pump, and teal-
blue dust
cap. It contains 17 g of product
formulation, 120 sprays, each delivering 50 µg of mometasone
furoate per actuation. Supplied
with Patient’s Instructions for Use (NDC 0085-1197-01).
Store between 2° and 25° C (36° and 77° F). Protect
from light.
When NASONEX Nasal Spray, 50 µg is removed from its cardboard
container, prolonged exposure
of the product to direct
light should be avoided.
Brief exposure to light,
as with normal use, is
acceptable.
SHAKE WELL BEFORE EACH USE.
top
